tiprankstipranks
Advertisement
Advertisement

NL:PHARM Stock Latest News

Pharming’s Joenja granted marketing authorization by European Commission
The FlyPharming’s Joenja granted marketing authorization by European Commission
3d ago
PHAR
Pharming Group Balances Near-Term Strain With Joenja Growth
PremiumCompany Announcements
Pharming Group Balances Near-Term Strain With Joenja Growth
6d ago
Pharming price target lowered to $40 from $41 at Oppenheimer
PremiumThe Fly
Pharming price target lowered to $40 from $41 at Oppenheimer
18d ago
PHAR
Pharming Group Balances Short-Term Strain With Pipeline Gains
PremiumCompany Announcements
Pharming Group Balances Short-Term Strain With Pipeline Gains
18d ago
Pharming reports Q1 EPS 1c, consensus 0c
PremiumThe Fly
Pharming reports Q1 EPS 1c, consensus 0c
19d ago
PHAR
Pharming sees FY26 revenue $405M-$425M, consensus $411.9M
PremiumThe FlyPharming sees FY26 revenue $405M-$425M, consensus $411.9M
19d ago
PHAR
Pharming initiated with a Buy at Canaccord on growth potential
Premium
The Fly
Pharming initiated with a Buy at Canaccord on growth potential
2M ago
PHAR
Pharming initiated with a Buy at Canaccord
Premium
The Fly
Pharming initiated with a Buy at Canaccord
2M ago
PHAR
Pharming announces approval of Joenja in Japan for patients aged 4 years and old
PremiumThe Fly
Pharming announces approval of Joenja in Japan for patients aged 4 years and old
2M ago
PHAR
Pharming price target lowered to $41 from $42 at Oppenheimer
PremiumThe Fly
Pharming price target lowered to $41 from $42 at Oppenheimer
2M ago
PHAR
Pharming: Solid Execution, Resilient Revenue, and Joenja Growth Support Buy Rating Ahead of Key Leniolisib Catalysts
PremiumRatings
Pharming: Solid Execution, Resilient Revenue, and Joenja Growth Support Buy Rating Ahead of Key Leniolisib Catalysts
2M ago
PHAR
Is PHGUF a Buy, Before Earnings?
PremiumPre-Earnings
Is PHGUF a Buy, Before Earnings?
3M ago
Morning Movers: Disney dips following fourth quarter earnings
PremiumThe FlyMorning Movers: Disney dips following fourth quarter earnings
4M ago
DIS
DVN
Pharming to host virtual investor day
Premium
The Fly
Pharming to host virtual investor day
4M ago
PHAR
Pharming Hit by FDA Setback on Joenja Pediatric Expansion but Adult Approval Unaffected
Premium
Company Announcements
Pharming Hit by FDA Setback on Joenja Pediatric Expansion but Adult Approval Unaffected
4M ago
Pharming receives CRL from U.S. FDA for sNDA for Joenja
PremiumThe Fly
Pharming receives CRL from U.S. FDA for sNDA for Joenja
4M ago
PHAR
Pharming price target raised to $42 from $41 at Oppenheimer
PremiumThe Fly
Pharming price target raised to $42 from $41 at Oppenheimer
7M ago
PHAR
Pharming Group Reports Strong Q3 2025 Growth
PremiumCompany Announcements
Pharming Group Reports Strong Q3 2025 Growth
7M ago
Pharming Group N.V. Reports Strong Q3 2025 Earnings
PremiumCompany Announcements
Pharming Group N.V. Reports Strong Q3 2025 Earnings
7M ago
PHGUF Upcoming Earnings Report: What to Expect?
PremiumPre-EarningsPHGUF Upcoming Earnings Report: What to Expect?
7M ago
Pharming announces 20% net reduction in non-commercial, non-medical headcount
Premium
The Fly
Pharming announces 20% net reduction in non-commercial, non-medical headcount
8M ago
PHAR
Pharming Group’s Leniolisib Gains FDA Approval for Pediatric Use, Expanding Market Potential
Premium
Ratings
Pharming Group’s Leniolisib Gains FDA Approval for Pediatric Use, Expanding Market Potential
8M ago
PHAR

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >